Pro104 antibody compositions and methods of use

Details Pro104 antibody compositions and methods of use Pro104 antibody compositions and methods of use

2009-01-15

2011-12-20

Whiteman, Brian (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

08080650

ABSTRACT:
The invention provides isolated anti-ovarian, pancreatic, lung or breast cancer antigen (Pro104) antibodies that bind to Pro104 on a mammalian cell in vivo. The invention also encompasses compositions comprising an anti-Pro104 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro104 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro104 antibodies. The invention encompasses a method of producing the anti-Pro104 antibodies. Other aspects of the invention are a method of killing a Pro104-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro104 antibody and a method of alleviating or treating a Pro104-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-Pro104 antibody to the mammal.

REFERENCES:
patent: 6180370 (2001-01-01), Queen et al.
patent: 6203979 (2001-03-01), Bandman et al.
patent: 6333410 (2001-12-01), Chari et al.
patent: 6479274 (2002-11-01), Antalis et al.
patent: 7618814 (2009-11-01), Bentwich
patent: 7709616 (2010-05-01), Bentwich et al.
patent: 2004/0146862 (2004-07-01), Mack et al.
patent: 2007/0031844 (2007-02-01), Khvorova et al.
patent: WO 98/36054 (1998-08-01), None
Bass (2001, Nature, v.411:428-9).
Elbashir, et al. (2001, Nature, v.411:494-8).
Elbashir, et al. (2001, EMBO J., v.20:6877-88).
Hooper et al. Biochim Biophys Acta. 2000 1492, 63-71.
EMBL Accession No. AA525010 Jul. 19, 1997.
Blok et al., “Isolation of cDNAs That Are Differentially Expressed Between Androgen-Dependent and Androgen-Independent Prostate Carcinoma Cells Using Differential Display PCT”, The Prostate 1995 26:213-224.
Chang et al., “Differentially Expressed Genes in Androgen-dependent and -independent Prostate Carcinomas”, Cancer Research 1997 57:4075-4081.
Friedrich et al., “Differentiation-Stage Specific Expression of Oncoprotein 18 in Human and Rat Prostatic Adenocarcinoma”, The Prostate 1995 27:102-109.
Hooper et al., “Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors”, Cancer Research 1999 59:3199-3205.
Inoue et al., “Cloning and Tissue Distribution of a Novel Serine Protease esp-1 from Human Eosinophils”, Biochemical and Biophysical Research Communications 1998 252:307-312.
Fundamental Immunology 242 William E. Paul, M.D. ed., 3d ed. p. 242, 1993.

Affiliated with

Also associated with

Rating

Pro104 antibody compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pro104 antibody compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro104 antibody compositions and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4305785